Unicycive Therapeutics Statistics
Total Valuation
UNCY has a market cap or net worth of $37.88 million. The enterprise value is $28.98 million.
| Market Cap | 37.88M |
| Enterprise Value | 28.98M |
Important Dates
The next estimated earnings date is Tuesday, May 14, 2024, before market open.
| Earnings Date | May 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
UNCY has 34.76 million shares outstanding. The number of shares has increased by 62.98% in one year.
| Shares Outstanding | 34.76M |
| Shares Change (YoY) | +62.98% |
| Shares Change (QoQ) | -24.80% |
| Owned by Insiders (%) | 18.40% |
| Owned by Institutions (%) | 49.18% |
| Float | 13.74M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.76
| Current Ratio | 0.76 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -371.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -150.10% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.24M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -36.63% in the last 52 weeks. The beta is 2.65, so UNCY's price volatility has been higher than the market average.
| Beta (1Y) | 2.65 |
| 52-Week Price Change | -36.63% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 0.96 |
| Relative Strength Index (RSI) | 33.42 |
| Average Volume (30 Days) | 369,806 |
Short Selling Information
The latest short interest is 256,780, so 0.74% of the outstanding shares have been sold short.
| Short Interest | 256,780 |
| Short Previous Month | 56,726 |
| Short % of Shares Out | 0.74% |
| Short % of Float | 1.87% |
| Short Ratio (days to cover) | 0.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -21.45M |
| Pretax Income | -30.54M |
| Net Income | -31.41M |
| EBITDA | -30.18M |
| EBIT | -30.46M |
| Earnings Per Share (EPS) | -$1.28 |
Balance Sheet
The company has $9.70 million in cash and $793,000 in debt, giving a net cash position of $8.91 million or $0.26 per share.
| Cash & Cash Equivalents | 9.70M |
| Total Debt | 793,000 |
| Net Cash | 8.91M |
| Net Cash Per Share | $0.26 |
| Equity / Book Value | -3.81M |
| Book Value Per Share | -0.11 |
| Working Capital | -4.14M |
Cash Flow
In the last 12 months, operating cash flow was -$18.28 million and capital expenditures -$12,000, giving a free cash flow of -$18.30 million.
| Operating Cash Flow | -18.28M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | -18.30M |
| FCF Per Share | -$0.75 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
UNCY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.98% |
| Shareholder Yield | -62.98% |
| Earnings Yield | -82.91% |
| FCF Yield | -48.29% |
Analyst Forecast
The average price target for UNCY is $5.50, which is 404.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.50 |
| Price Target Difference | 404.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |